Spectrophotometric determination of raloxifene hydrochloride in pharmaceutical formulations

E-Journal of Chemistry

Volumn 4, Issue 1, 2007, Pages 79-82

  Mathrusri Annapurna, M ^a   Bhanoji Rao, M E ^a   Ravi Kumar, B V V ^a  

^a ROLAND INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

1, 10 phenanthroline; 2, 2 bipyridyl; Raloxifene hydrochloride; Sodium hydroxide

Indexed keywords

EID: 33847790447     PISSN: None     EISSN: 09734945     Source Type: Journal    
DOI: 10.1155/2007/480625     Document Type: Article

References (9)

1. th Edition, Merck Research Laboratories, Division of Merck and Co., Inc; White house station, NJ, 2001, 1452.
2. Cummings S R, J. Am. Med. Assoc., 1997, 281, 2189.
3. Hol T, Cox M B, Bryant H U and Draper M W J, Womens Health 1997, 6, 523.
4. Ettinger B ibid., 1999, 282, 637.
5. Delmas P, Bjarnason N H, Mitlak B H, Ravoux A C, Shah A S, Huster W J, Draper A and Christiansen C N, Engl. J. Med. 1997, 337, 1641.
6. Zweigenbaum J and Henion J, Anal. Chem. 2000, 72, 2446.
7. Nandini P and Jayant W P, Indian Drugs, 2001, 38, 591.
8. Wang Q, Zhang H M, Yu Z G and Shenyang Yaoke Daxue Xuebao, 2002, 19, 105.
9. Venkata Reddy P, Sudha Rani B, Srinubabu G and Seshagiri Rao J V L N, E- J. Chem. 2006, 3(10), 60.